Total Payments
$2,415
2024 Payments
$625.16
Companies
35
Transactions
117
Medicare Patients
28,588
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$2,190 (90.7%)
Education$225.10 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,190 | 112 | 90.7% |
| Education | $225.10 | 5 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $330.66 | 9 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $248.51 | 10 | $0 (2019) |
| Daiichi Sankyo Inc. | $201.91 | 12 | $0 (2024) |
| Travere Therapeutics, Inc. | $201.34 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $108.40 | 4 | $0 (2019) |
| Relypsa, Inc. | $93.49 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $92.80 | 6 | $0 (2024) |
| Calliditas Therapeutics US Inc. | $88.72 | 4 | $0 (2023) |
| ANI Pharmaceuticals, Inc. | $88.60 | 4 | $0 (2024) |
| Horizon Therapeutics plc | $84.71 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $625.16 | 29 | Mallinckrodt Hospital Products Inc. ($154.10) |
| 2023 | $489.51 | 22 | Travere Therapeutics, Inc. ($110.33) |
| 2022 | $260.05 | 11 | Mallinckrodt Hospital Products Inc. ($124.67) |
| 2021 | $12.17 | 1 | Medtronic, Inc. ($12.17) |
| 2020 | $95.95 | 6 | Horizon Therapeutics plc ($28.08) |
| 2019 | $306.42 | 17 | Otsuka America Pharmaceutical, Inc. ($76.16) |
| 2018 | $334.25 | 18 | Mallinckrodt LLC ($108.41) |
| 2017 | $291.52 | 13 | Mallinckrodt LLC ($91.76) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.28 | General |
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 08/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 08/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/12/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 06/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $83.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: HEMATOLOGY | ||||||
| 04/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Rare Disease | ||||||
| 03/27/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/27/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $32.48 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 6,595 | 36,435 | $1.7M | $501,991 |
| 2022 | 38 | 6,235 | 26,781 | $1.5M | $466,334 |
| 2021 | 35 | 7,895 | 42,670 | $1.9M | $571,282 |
| 2020 | 39 | 7,863 | 56,898 | $2.1M | $592,345 |
Total Patients
28,588
Total Services
162,784
Medicare Billing
$2.1M
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 672 | 1,630 | $315,290 | $143,257 | 45.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 46 | 279 | $131,130 | $62,049 | 47.3% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 25 | 23,971 | $335,594 | $55,787 | 16.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 160 | 724 | $117,288 | $43,400 | 37.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 612 | 1,031 | $191,766 | $41,553 | 21.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 448 | 677 | $142,847 | $19,533 | 13.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 144 | 195 | $56,550 | $18,998 | 33.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 28 | 54 | $30,564 | $14,548 | 47.6% |
| 80069 | Kidney function blood test panel | Office | 2023 | 700 | 1,557 | $102,762 | $13,198 | 12.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 700 | 1,546 | $35,558 | $12,942 | 36.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 50 | 214 | $39,567 | $11,697 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 206 | $30,074 | $11,647 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $29,585 | $11,139 | 37.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 30 | 59 | $22,715 | $8,906 | 39.2% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 71 | 426 | $23,856 | $7,414 | 31.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 458 | 690 | $41,400 | $5,232 | 12.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 495 | 787 | $24,397 | $4,972 | 20.4% |
| 83550 | Iron binding capacity | Office | 2023 | 240 | 394 | $15,760 | $3,366 | 21.4% |
| 83540 | Iron level | Office | 2023 | 239 | 395 | $10,665 | $2,496 | 23.4% |
| 83735 | Magnesium level | Office | 2023 | 216 | 303 | $8,181 | $1,986 | 24.3% |
| 84100 | Phosphate level | Office | 2023 | 185 | 246 | $5,904 | $1,135 | 19.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 103 | $4,841 | $1,068 | 22.1% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2023 | 71 | 71 | $4,331 | $947.72 | 21.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 142 | 167 | $3,841 | $834.81 | 21.7% |
| 86038 | Screening test for autoimmune disorder | Office | 2023 | 71 | 71 | $2,911 | $833.46 | 28.6% |
About Patrick Fluck
Patrick Fluck is a Nephrology healthcare provider based in Hutchinson, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659341394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Fluck has received a total of $2,415 in payments from pharmaceutical and medical device companies, with $625.16 received in 2024. These payments were reported across 117 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,190).
As a Medicare-enrolled provider, Fluck has provided services to 28,588 Medicare beneficiaries, totaling 162,784 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Hutchinson, KS
- Active Since 01/25/2006
- Last Updated 09/18/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1659341394
Products in Payments
- ACTHAR (Biological) $579.17
- INJECTAFER (Drug) $201.91
- Veltassa (Drug) $148.52
- TARPEYO (Drug) $88.72
- PURIFIED CORTROPHIN GEL (Drug) $88.60
- FARXIGA (Drug) $79.93
- SAMSCA (Drug) $75.80
- Crysvita (Drug) $63.89
- Rayaldee (Drug) $57.63
- DALVANCE (Drug) $55.48
- AURYXIA (Drug) $53.64
- RENVELA (Drug) $47.51
- KRYSTEXXA (Biological) $43.62
- RAYOS (Drug) $41.09
- ENTRESTO (Drug) $40.54
- TAVNEOS (Drug) $40.07
- Parsabiv (Biological) $37.36
- Rybelsus (Drug) $34.53
- (815) Thiola (Drug) $33.59
- JYNARQUE (Drug) $32.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.